25 XP   0   0   10

PYC Therapeutics Ltd
Buy, Hold or Sell?

Let's analyse PYC Therapeutics Ltd together

PenkeI guess you are interested in PYC Therapeutics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PYC Therapeutics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about PYC Therapeutics Ltd

I send you an email if I find something interesting about PYC Therapeutics Ltd.

Quick analysis of PYC Therapeutics Ltd (30 sec.)










What can you expect buying and holding a share of PYC Therapeutics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.01
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$0.00
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
-1.3%

For what price can you sell your share?

Current Price per Share
A$0.09
Expected price per share
A$0.077082352941177 - A$0.11501976284585
How sure are you?
50%

1. Valuation of PYC Therapeutics Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.09

Intrinsic Value Per Share

A$-0.09 - A$-0.04

Total Value Per Share

A$-0.08 - A$-0.03

2. Growth of PYC Therapeutics Ltd (5 min.)




Is PYC Therapeutics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$18.2m$25.7m-$7.5m-41.3%

How much money is PYC Therapeutics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$14.5m-$8.8m-$5.7m-39.2%
Net Profit Margin-144.2%-86.4%--

How much money comes from the company's main activities?

3. Financial Health of PYC Therapeutics Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#605 / 1019

Most Revenue
#302 / 1019

Most Profit
#624 / 1019

Most Efficient
#606 / 1019

What can you expect buying and holding a share of PYC Therapeutics Ltd? (5 min.)

Welcome investor! PYC Therapeutics Ltd's management wants to use your money to grow the business. In return you get a share of PYC Therapeutics Ltd.

What can you expect buying and holding a share of PYC Therapeutics Ltd?

First you should know what it really means to hold a share of PYC Therapeutics Ltd. And how you can make/lose money.

Speculation

The Price per Share of PYC Therapeutics Ltd is A$0.091. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of PYC Therapeutics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in PYC Therapeutics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of PYC Therapeutics Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-3.8%0.00-3.8%0.00-2.3%0.00-2.2%0.00-1.4%
Usd Book Value Change Per Share0.00-2.0%0.00-2.0%0.00-2.3%0.000.9%0.000.5%
Usd Dividend Per Share0.001.7%0.001.7%0.000.0%0.002.3%0.001.2%
Usd Total Gains Per Share0.00-0.2%0.00-0.2%0.00-2.3%0.003.2%0.001.6%
Usd Price Per Share0.04-0.04-0.04-0.05-0.03-
Price to Earnings Ratio-10.53--10.53--20.09--34.12--34.04-
Price-to-Total Gains Ratio-185.33--185.33--20.30--31.50--11.30-
Price to Book Ratio8.44-8.44-6.93-12.74-27.00-
Price-to-Total Gains Ratio-185.33--185.33--20.30--31.50--11.30-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0582764
Number of shares17159
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (17159 shares)-3.3650.37
Gains per Year (17159 shares)-13.45201.47
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1109-122-2314656191
2217-244-36292111392
3326-366-49437167593
4435-488-62583223794
5543-611-75729278995
6652-733-888753341196
7761-855-10110213901397
8869-977-11411674451598
9978-1099-12713125011799
101087-1221-14014585562000

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.019.01.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%6.04.00.060.0%11.09.00.055.0%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%3.00.02.060.0%3.00.07.030.0%3.00.017.015.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%6.04.00.060.0%11.09.00.055.0%

Fundamentals of PYC Therapeutics Ltd

About PYC Therapeutics Ltd

PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of RNA therapeutics in Australia. The company's preclinical development programs include VP-001, a drug program for retinitis pigmentosa type 11; PYC-001, a drug program for the treatment of autosomal dominant optic atrophy; and PYC-002 a drug program for the treatment of a severe neurodevelopmental disorder. It also focuses on the development of programs for kidney, neurodevelopmental, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.

Fundamental data was last updated by Penke on 2024-04-03 05:06:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of PYC Therapeutics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit PYC Therapeutics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare PYC Therapeutics Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -144.2% means that $-1.44 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PYC Therapeutics Ltd:

  • The MRQ is -144.2%. The company is making a huge loss. -2
  • The TTM is -144.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-144.2%TTM-144.2%0.0%
TTM-144.2%YOY-86.4%-57.8%
TTM-144.2%5Y-326,600.1%+326,455.9%
5Y-326,600.1%10Y-201,903.9%-124,696.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-144.2%-196.9%+52.7%
TTM-144.2%-211.2%+67.0%
YOY-86.4%-279.3%+192.9%
5Y-326,600.1%-436.8%-326,163.3%
10Y-201,903.9%-599.3%-201,304.6%
1.1.2. Return on Assets

Shows how efficient PYC Therapeutics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare PYC Therapeutics Ltd to the Biotechnology industry mean.
  • -61.3% Return on Assets means that PYC Therapeutics Ltd generated $-0.61 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PYC Therapeutics Ltd:

  • The MRQ is -61.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -61.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-61.3%TTM-61.3%0.0%
TTM-61.3%YOY-30.6%-30.7%
TTM-61.3%5Y-41.0%-20.3%
5Y-41.0%10Y-73.6%+32.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-61.3%-13.6%-47.7%
TTM-61.3%-12.9%-48.4%
YOY-30.6%-11.9%-18.7%
5Y-41.0%-14.2%-26.8%
10Y-73.6%-16.2%-57.4%
1.1.3. Return on Equity

Shows how efficient PYC Therapeutics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare PYC Therapeutics Ltd to the Biotechnology industry mean.
  • -82.1% Return on Equity means PYC Therapeutics Ltd generated $-0.82 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PYC Therapeutics Ltd:

  • The MRQ is -82.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -82.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-82.1%TTM-82.1%0.0%
TTM-82.1%YOY-35.2%-46.9%
TTM-82.1%5Y-47.9%-34.2%
5Y-47.9%10Y-118.0%+70.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-82.1%-17.0%-65.1%
TTM-82.1%-16.1%-66.0%
YOY-35.2%-15.4%-19.8%
5Y-47.9%-20.0%-27.9%
10Y-118.0%-21.1%-96.9%

1.2. Operating Efficiency of PYC Therapeutics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient PYC Therapeutics Ltd is operating .

  • Measures how much profit PYC Therapeutics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare PYC Therapeutics Ltd to the Biotechnology industry mean.
  • An Operating Margin of -247.8% means the company generated $-2.48  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PYC Therapeutics Ltd:

  • The MRQ is -247.8%. The company is operating very inefficient. -2
  • The TTM is -247.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-247.8%TTM-247.8%0.0%
TTM-247.8%YOY-188.3%-59.5%
TTM-247.8%5Y-568,478.3%+568,230.5%
5Y-568,478.3%10Y-344,267.3%-224,211.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-247.8%-282.4%+34.6%
TTM-247.8%-225.8%-22.0%
YOY-188.3%-288.4%+100.1%
5Y-568,478.3%-475.2%-568,003.1%
10Y-344,267.3%-624.7%-343,642.6%
1.2.2. Operating Ratio

Measures how efficient PYC Therapeutics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.48 means that the operating costs are $2.48 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of PYC Therapeutics Ltd:

  • The MRQ is 2.478. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.478. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.478TTM2.4780.000
TTM2.478YOY1.883+0.595
TTM2.4785Y7,154.719-7,152.241
5Y7,154.71910Y4,242.520+2,912.199
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4782.994-0.516
TTM2.4783.247-0.769
YOY1.8833.766-1.883
5Y7,154.7195.675+7,149.044
10Y4,242.5207.857+4,234.663

1.3. Liquidity of PYC Therapeutics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if PYC Therapeutics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.79 means the company has $3.79 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of PYC Therapeutics Ltd:

  • The MRQ is 3.792. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.792. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.792TTM3.7920.000
TTM3.792YOY8.945-5.153
TTM3.7925Y16.028-12.236
5Y16.02810Y10.102+5.926
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7923.930-0.138
TTM3.7924.251-0.459
YOY8.9455.436+3.509
5Y16.0286.045+9.983
10Y10.1026.383+3.719
1.3.2. Quick Ratio

Measures if PYC Therapeutics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare PYC Therapeutics Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 3.79 means the company can pay off $3.79 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PYC Therapeutics Ltd:

  • The MRQ is 3.786. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.786. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.786TTM3.7860.000
TTM3.786YOY8.929-5.143
TTM3.7865Y32.202-28.416
5Y32.20210Y18.186+14.016
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7863.629+0.157
TTM3.7864.065-0.279
YOY8.9295.390+3.539
5Y32.2025.993+26.209
10Y18.1866.277+11.909

1.4. Solvency of PYC Therapeutics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of PYC Therapeutics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare PYC Therapeutics Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.23 means that PYC Therapeutics Ltd assets are financed with 23.5% credit (debt) and the remaining percentage (100% - 23.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PYC Therapeutics Ltd:

  • The MRQ is 0.235. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.235. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.235TTM0.2350.000
TTM0.235YOY0.114+0.121
TTM0.2355Y0.104+0.131
5Y0.10410Y0.202-0.098
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2350.332-0.097
TTM0.2350.333-0.098
YOY0.1140.268-0.154
5Y0.1040.366-0.262
10Y0.2020.390-0.188
1.4.2. Debt to Equity Ratio

Measures if PYC Therapeutics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare PYC Therapeutics Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 31.4% means that company has $0.31 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PYC Therapeutics Ltd:

  • The MRQ is 0.314. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.314. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.314TTM0.3140.000
TTM0.314YOY0.131+0.184
TTM0.3145Y0.126+0.188
5Y0.12610Y0.320-0.193
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3140.380-0.066
TTM0.3140.389-0.075
YOY0.1310.334-0.203
5Y0.1260.432-0.306
10Y0.3200.465-0.145

2. Market Valuation of PYC Therapeutics Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings PYC Therapeutics Ltd generates.

  • Above 15 is considered overpriced but always compare PYC Therapeutics Ltd to the Biotechnology industry mean.
  • A PE ratio of -10.53 means the investor is paying $-10.53 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PYC Therapeutics Ltd:

  • The EOD is -16.903. Based on the earnings, the company is expensive. -2
  • The MRQ is -10.532. Based on the earnings, the company is expensive. -2
  • The TTM is -10.532. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.903MRQ-10.532-6.371
MRQ-10.532TTM-10.5320.000
TTM-10.532YOY-20.091+9.559
TTM-10.5325Y-34.120+23.588
5Y-34.12010Y-34.041-0.079
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-16.903-2.426-14.477
MRQ-10.532-2.552-7.980
TTM-10.532-2.656-7.876
YOY-20.091-4.143-15.948
5Y-34.120-6.252-27.868
10Y-34.041-6.108-27.933
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of PYC Therapeutics Ltd:

  • The EOD is -15.462. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.634. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -9.634. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.462MRQ-9.634-5.828
MRQ-9.634TTM-9.6340.000
TTM-9.634YOY-12.564+2.930
TTM-9.6345Y-36.442+26.808
5Y-36.44210Y-36.4420.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-15.462-3.199-12.263
MRQ-9.634-3.259-6.375
TTM-9.634-3.552-6.082
YOY-12.564-5.617-6.947
5Y-36.442-8.326-28.116
10Y-36.442-8.689-27.753
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of PYC Therapeutics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 8.44 means the investor is paying $8.44 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of PYC Therapeutics Ltd:

  • The EOD is 13.543. Based on the equity, the company is expensive. -2
  • The MRQ is 8.438. Based on the equity, the company is overpriced. -1
  • The TTM is 8.438. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD13.543MRQ8.438+5.105
MRQ8.438TTM8.4380.000
TTM8.438YOY6.928+1.510
TTM8.4385Y12.736-4.298
5Y12.73610Y26.998-14.262
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD13.5431.947+11.596
MRQ8.4382.116+6.322
TTM8.4382.095+6.343
YOY6.9282.836+4.092
5Y12.7363.443+9.293
10Y26.9983.791+23.207
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of PYC Therapeutics Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of PYC Therapeutics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.003-0.0030%-0.003+17%0.001-319%0.001-532%
Book Value Per Share--0.0070.0070%0.009-29%0.008-11%0.004+58%
Current Ratio--3.7923.7920%8.945-58%16.028-76%10.102-62%
Debt To Asset Ratio--0.2350.2350%0.114+107%0.104+126%0.202+16%
Debt To Equity Ratio--0.3140.3140%0.131+140%0.126+149%0.320-2%
Dividend Per Share--0.0020.0020%-+100%0.003-25%0.002+49%
Eps---0.005-0.0050%-0.003-39%-0.003-43%-0.002-63%
Free Cash Flow Per Share---0.006-0.0060%-0.005-11%-0.003-43%-0.002-64%
Free Cash Flow To Equity Per Share---0.003-0.0030%-0.005+66%0.001-632%0.001-691%
Gross Profit Margin--1.0421.0420%1.069-3%1.0450%1.023+2%
Intrinsic Value_10Y_max---0.042--------
Intrinsic Value_10Y_min---0.090--------
Intrinsic Value_1Y_max---0.003--------
Intrinsic Value_1Y_min---0.006--------
Intrinsic Value_3Y_max---0.009--------
Intrinsic Value_3Y_min---0.020--------
Intrinsic Value_5Y_max---0.017--------
Intrinsic Value_5Y_min---0.038--------
Market Cap385191159.808+38%240003722.650240003722.6500%278522838.630-14%359793940.480-33%229336890.532+5%
Net Profit Margin---1.442-1.4420%-0.864-40%-3266.001+226427%-2019.039+139939%
Operating Margin---2.478-2.4780%-1.883-24%-5684.783+229338%-3442.673+138846%
Operating Ratio--2.4782.4780%1.883+32%7154.719-100%4242.520-100%
Pb Ratio13.543+38%8.4388.4380%6.928+22%12.736-34%26.998-69%
Pe Ratio-16.903-60%-10.532-10.5320%-20.091+91%-34.120+224%-34.041+223%
Price Per Share0.091+38%0.0570.0570%0.066-14%0.085-33%0.054+5%
Price To Free Cash Flow Ratio-15.462-60%-9.634-9.6340%-12.564+30%-36.442+278%-36.442+278%
Price To Total Gains Ratio-297.449-60%-185.334-185.3340%-20.298-89%-31.502-83%-11.299-94%
Quick Ratio--3.7863.7860%8.929-58%32.202-88%18.186-79%
Return On Assets---0.613-0.6130%-0.306-50%-0.410-33%-0.736+20%
Return On Equity---0.821-0.8210%-0.352-57%-0.479-42%-1.180+44%
Total Gains Per Share--0.0000.0000%-0.003+960%0.005-107%0.002-113%
Usd Book Value--18214640.40018214640.4000%25745550.999-29%20372924.292-11%11532407.669+58%
Usd Book Value Change Per Share---0.002-0.0020%-0.002+17%0.001-319%0.000-532%
Usd Book Value Per Share--0.0040.0040%0.006-29%0.005-11%0.003+58%
Usd Dividend Per Share--0.0020.0020%-+100%0.002-25%0.001+49%
Usd Eps---0.003-0.0030%-0.002-39%-0.002-43%-0.001-63%
Usd Free Cash Flow---15954158.401-15954158.4010%-14197150.557-11%-9079904.740-43%-5688884.852-64%
Usd Free Cash Flow Per Share---0.004-0.0040%-0.003-11%-0.002-43%-0.001-64%
Usd Free Cash Flow To Equity Per Share---0.002-0.0020%-0.003+66%0.000-632%0.000-691%
Usd Market Cap246676418.741+38%153698383.985153698383.9850%178366025.859-14%230412039.483-33%146867344.697+5%
Usd Price Per Share0.058+38%0.0360.0360%0.042-14%0.054-33%0.035+5%
Usd Profit---14594065.994-14594065.9940%-8877967.024-39%-8366405.001-43%-5439198.528-63%
Usd Revenue--10122326.34210122326.3420%10273822.568-1%4779868.880+112%2663086.622+280%
Usd Total Gains Per Share--0.0000.0000%-0.002+960%0.003-107%0.001-113%
 EOD+5 -3MRQTTM+0 -0YOY+9 -275Y+6 -3010Y+17 -19

4.2. Fundamental Score

Let's check the fundamental score of PYC Therapeutics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-16.903
Price to Book Ratio (EOD)Between0-113.543
Net Profit Margin (MRQ)Greater than0-1.442
Operating Margin (MRQ)Greater than0-2.478
Quick Ratio (MRQ)Greater than13.786
Current Ratio (MRQ)Greater than13.792
Debt to Asset Ratio (MRQ)Less than10.235
Debt to Equity Ratio (MRQ)Less than10.314
Return on Equity (MRQ)Greater than0.15-0.821
Return on Assets (MRQ)Greater than0.05-0.613
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of PYC Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.400
Ma 20Greater thanMa 500.088
Ma 50Greater thanMa 1000.084
Ma 100Greater thanMa 2000.088
OpenGreater thanClose0.097
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets37,166
Total Liabilities8,723
Total Stockholder Equity27,750
 As reported
Total Liabilities 8,723
Total Stockholder Equity+ 27,750
Total Assets = 37,166

Assets

Total Assets37,166
Total Current Assets31,873
Long-term Assets5,293
Total Current Assets
Cash And Cash Equivalents 15,572
Net Receivables 16,252
Other Current Assets 50
Total Current Assets  (as reported)31,873
Total Current Assets  (calculated)31,873
+/-0
Long-term Assets
Property Plant Equipment 1,043
Intangible Assets 4,250
Other Assets 0
Long-term Assets  (as reported)5,293
Long-term Assets  (calculated)5,293
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities8,406
Long-term Liabilities318
Total Stockholder Equity27,750
Total Current Liabilities
Short-term Debt 178
Accounts payable 4,919
Other Current Liabilities 3,309
Total Current Liabilities  (as reported)8,406
Total Current Liabilities  (calculated)8,406
+/-0
Long-term Liabilities
Long term Debt Total 138
Other Liabilities 180
Long-term Liabilities  (as reported)318
Long-term Liabilities  (calculated)318
+/- 0
Total Stockholder Equity
Common Stock140,087
Retained Earnings -118,169
Accumulated Other Comprehensive Income 5,832
Total Stockholder Equity (as reported)27,750
Total Stockholder Equity (calculated)27,750
+/-0
Other
Capital Stock140,087
Cash And Equivalents15,572
Cash and Short Term Investments 15,572
Common Stock Shares Outstanding 3,210,594
Current Deferred Revenue-178
Liabilities and Stockholders Equity 37,166
Net Debt -15,256
Net Invested Capital 27,750
Net Tangible Assets 23,500
Net Working Capital 23,468
Property Plant and Equipment Gross 4,188
Short Long Term Debt Total 315



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-30
> Total Assets 
1,174
6,084
2,832
3,534
3,519
3,487
1,570
5,661
3,495
2,262
4,524
1,786
7,266
10,348
3,419
6,701
31,546
57,941
45,352
37,166
37,16645,35257,94131,5466,7013,41910,3487,2661,7864,5242,2623,4955,6611,5703,4873,5193,5342,8326,0841,174
   > Total Current Assets 
0
5,578
2,758
3,419
3,323
3,414
1,405
5,375
3,016
1,926
4,194
1,623
7,199
10,132
3,276
6,218
25,561
51,781
39,249
31,873
31,87339,24951,78125,5616,2183,27610,1327,1991,6234,1941,9263,0165,3751,4053,4143,3233,4192,7585,5780
       Cash And Cash Equivalents 
791
5,505
2,639
3,369
3,232
3,073
1,281
5,199
2,779
1,807
4,022
1,476
7,074
9,940
3,147
6,181
7,242
18,435
29,110
15,572
15,57229,11018,4357,2426,1813,1479,9407,0741,4764,0221,8072,7795,1991,2813,0733,2323,3692,6395,505791
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,186
18,186
33,067
0
0
0033,06718,18618,186000000000000000
       Net Receivables 
38
50
11
30
60
342
124
113
237
119
172
119
126
192
128
11
83
186
10,071
16,252
16,25210,07118683111281921261191721192371131243426030115038
       Other Current Assets 
0
22
108
21
31
0
0
62
0
0
0
28
0
0
0
26
50
93
68
50
50689350260002800062003121108220
   > Long-term Assets 
0
507
74
115
196
73
165
287
479
337
330
163
67
216
143
483
5,985
6,160
6,103
5,293
5,2936,1036,1605,9854831432166716333033747928716573196115745070
       Property Plant Equipment 
4
40
74
115
196
73
165
287
479
337
330
163
67
216
143
483
1,135
1,486
1,629
1,043
1,0431,6291,4861,135483143216671633303374792871657319611574404
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300
0
0
0
0003000000000000000000
       Intangible Assets 
340
466
0
0
0
0
0
0
0
0
0
0
0
0
0
4,850
4,850
4,650
4,450
4,250
4,2504,4504,6504,8504,8500000000000000466340
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24
24
0
0242400000000000000000
> Total Liabilities 
628
304
718
1,337
824
1,576
2,007
1,308
801
1,068
805
824
1,436
1,489
1,772
402
1,351
4,017
5,149
8,723
8,7235,1494,0171,3514021,7721,4891,4368248051,0688011,3082,0071,5768241,337718304628
   > Total Current Liabilities 
628
304
718
1,326
814
535
1,982
1,259
777
1,049
800
824
1,436
1,489
1,772
402
706
3,297
4,388
8,406
8,4064,3883,2977064021,7721,4891,4368248001,0497771,2591,9825358141,326718304628
       Short-term Debt 
0
0
13
10
7
0
1,238
0
0
0
0
0
0
0
0
153
153
188
260
178
178260188153153000000001,23807101300
       Accounts payable 
72
17
221
579
260
330
561
543
367
718
411
444
1,057
1,446
1,684
194
97
2,346
2,574
4,919
4,9192,5742,346971941,6841,4461,0574444117183675435613302605792211772
       Other Current Liabilities 
3
225
339
498
546
205
183
716
410
331
389
379
379
43
88
208
455
763
1,554
3,309
3,3091,55476345520888433793793893314107161832055464983392253
   > Long-term Liabilities 
0
0
0
11
10
1,041
25
50
25
18
6
0
0
0
0
645
645
720
762
318
31876272064564500006182550251,0411011000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
645
543
684
138
1386845436450000000000000000
       Other Liabilities 
0
0
0
11
10
13
25
50
25
18
6
0
0
0
0
0
0
177
78
180
18078177000000618255025131011000
> Total Stockholder Equity
546
5,781
2,114
2,197
2,695
1,911
-437
4,353
2,694
1,195
3,719
962
5,830
8,859
1,647
6,299
28,453
53,044
39,352
27,750
27,75039,35253,04428,4536,2991,6478,8595,8309623,7191,1952,6944,353-4371,9112,6952,1972,1145,781546
   Common Stock
899
7,721
7,820
11,710
16,676
20,093
21,973
30,367
32,456
34,056
39,666
39,666
48,456
53,209
53,334
61,951
87,207
125,991
125,991
140,087
140,087125,991125,99187,20761,95153,33453,20948,45639,66639,66634,05632,45630,36721,97320,09316,67611,7107,8207,721899
   Retained Earnings Total Equity00000000000000000000
   Accumulated Other Comprehensive Income 
0
-7
283
-49
-98
671
1,015
1,016
1,174
1,514
545
780
837
1,064
1,161
1,276
4,996
8,570
8,741
5,832
5,8328,7418,5704,9961,2761,1611,0648377805451,5141,1741,0161,015671-98-49283-70
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
545
780
837
1,064
1,161
1,276
-23,457
-44,474
-30,611
-21,918
-21,918-30,611-44,474-23,4571,2761,1611,0648377805450000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue15,806
Cost of Revenue-882
Gross Profit14,92414,924
 
Operating Income (+$)
Gross Profit14,924
Operating Expense-38,281
Operating Income-39,163-23,357
 
Operating Expense (+$)
Research Development35,146
Selling General Administrative4,091
Selling And Marketing Expenses956
Operating Expense38,28140,193
 
Net Interest Income (+$)
Interest Income82
Interest Expense-27
Other Finance Cost-0
Net Interest Income55
 
Pretax Income (+$)
Operating Income-39,163
Net Interest Income55
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-39,163-39,164
EBIT - interestExpense = -39,190
-38,595
-22,762
Interest Expense27
Earnings Before Interest and Taxes (EBIT)-39,163-39,135
Earnings Before Interest and Taxes (EBITDA)-38,281
 
After tax Income (+$)
Income Before Tax-39,163
Tax Provision-0
Net Income From Continuing Ops-23,356-39,163
Net Income-22,789
Net Income Applicable To Common Shares-22,789
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses39,163
Total Other Income/Expenses Net0-55
 

Technical Analysis of PYC Therapeutics Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of PYC Therapeutics Ltd. The general trend of PYC Therapeutics Ltd is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine PYC Therapeutics Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of PYC Therapeutics Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.11501976284585.

The bearish price targets are: 0.089 > 0.087940476190476 > 0.077082352941177.

Tweet this
PYC Therapeutics Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of PYC Therapeutics Ltd. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

PYC Therapeutics Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of PYC Therapeutics Ltd. The current macd is 0.00338153.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the PYC Therapeutics Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for PYC Therapeutics Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the PYC Therapeutics Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
PYC Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) ChartPYC Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of PYC Therapeutics Ltd. The current adx is 38.88.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy PYC Therapeutics Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
PYC Therapeutics Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of PYC Therapeutics Ltd. The current sar is 0.08983183.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
PYC Therapeutics Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of PYC Therapeutics Ltd. The current rsi is 53.40. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
PYC Therapeutics Ltd Daily Relative Strength Index (RSI) ChartPYC Therapeutics Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of PYC Therapeutics Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the PYC Therapeutics Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
PYC Therapeutics Ltd Daily Stochastic Oscillator ChartPYC Therapeutics Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of PYC Therapeutics Ltd. The current cci is 62.20.

PYC Therapeutics Ltd Daily Commodity Channel Index (CCI) ChartPYC Therapeutics Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of PYC Therapeutics Ltd. The current cmo is 3.42492964.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
PYC Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) ChartPYC Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of PYC Therapeutics Ltd. The current willr is -58.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that PYC Therapeutics Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
PYC Therapeutics Ltd Daily Williams %R ChartPYC Therapeutics Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of PYC Therapeutics Ltd.

PYC Therapeutics Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of PYC Therapeutics Ltd. The current atr is 0.00555425.

PYC Therapeutics Ltd Daily Average True Range (ATR) ChartPYC Therapeutics Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of PYC Therapeutics Ltd. The current obv is 26,524,398.

PYC Therapeutics Ltd Daily On-Balance Volume (OBV) ChartPYC Therapeutics Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of PYC Therapeutics Ltd. The current mfi is 64.49.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
PYC Therapeutics Ltd Daily Money Flow Index (MFI) ChartPYC Therapeutics Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for PYC Therapeutics Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

PYC Therapeutics Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of PYC Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.400
Ma 20Greater thanMa 500.088
Ma 50Greater thanMa 1000.084
Ma 100Greater thanMa 2000.088
OpenGreater thanClose0.097
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of PYC Therapeutics Ltd with someone you think should read this too:
  • Are you bullish or bearish on PYC Therapeutics Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about PYC Therapeutics Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about PYC Therapeutics Ltd

I send you an email if I find something interesting about PYC Therapeutics Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about PYC Therapeutics Ltd.

Receive notifications about PYC Therapeutics Ltd in your mailbox!